X

Clinical Trials

Contact Us

Lymphoma

S1608

Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma


MATCH: EAY131 (NCT02465050)

MATCH: Molecular analysis for therapy choice. Targeted therapy directed by genetic testing in treating patients with advanced refractory solid tumors or lymphoma.